KOSPI risks rise as Seoul watches chip swings

KOSPI risks are climbing as South Korea's finance ministry and regulators monitor chip-led swings, circuit breakers, and leveraged single-stock ETFs.

AI-generated Axo News staff avatar for Hiro Tanaka

Bundibugyo virus outbreak could top 20,000 cases

CDC models say the Bundibugyo virus outbreak in DRC and Uganda could exceed 20,000 cases in three months if isolation stays weak.

AI-generated Axo News staff avatar for Aisha Mensah

Summer hotel openings remake mountain and beach stays

Summer hotel openings stretch from Faraway Jackson Hole and White Elephant Aspen to Sublime Sand in Comporta and a regenerative Colorado ranch.

AI-generated Axo News staff avatar for Elena Petrov

Long Thanh airport shifts Vietnam long-haul traffic

Long Thanh airport is set for mid-2026 commercial ops outside Ho Chi Minh City, taking Europe and U.S. long-haul flights off congested Tan Son Nhat.

AI-generated Axo News staff avatar for Elena Petrov

Breast cancer survival gap hits 45 points by income

A breast cancer survival gap of about 45 points separates high- and low-income countries in WHO’s first global five-year estimates for 2017–2021.

AI-generated Axo News staff avatar for Aisha Mensah

Brazil tourism surge leads 2025 arrival growth

Brazil tourism surge hit 37% in 2025 as Embratur backed new flights and operators pushed travelers beyond Rio and Sao Paulo hubs.

AI-generated Axo News staff avatar for Elena Petrov

WHO projects cancer cases nearly double by 2050

WHO cancer cases nearly double by 2050 under current trends, with 20.6 million new cases a year and sharp survival gaps by income.

AI-generated Axo News staff avatar for Aisha Mensah

Italy reports first imported H9N2 case in Europe

WHO says Italy confirmed an imported H9N2 avian influenza case in a traveler from Senegal; general population risk remains low with no sustained human spread.

AI-generated Axo News staff avatar for Aisha Mensah

H3N2 subclade K complicates flu vaccine match

CDC says H3N2 subclade K is antigenically drifted from the 2025-2026 vaccine component, while early overseas vaccine effectiveness still looks useful.

AI-generated Axo News staff avatar for Aisha Mensah

FDA presses sponsors over missing trial results

FDA reminded 2,200-plus sponsors after finding nearly 30% of likely required studies lacked posted clinical trial results, STAT reported.

AI-generated Axo News staff avatar for Aisha Mensah